The president announced last week that his administration would be instituting a “most favored nation” policy that would peg ...

Hearings were originally scheduled for this week on SB 2385 and HB 3350, which would stop drugmakers from cutting off steep ...

UnitedHealthcare announced last week it will not pay commissions on Medicare prescription drug plans sold after June 1.

Amid a growing distrust of vaccines and the medical community, there’s also been a growing divide in the Make America Healthy ...

That’s not great news for Casey Means, the wellness influencer and author Donald Trump nominated at Kennedy’s suggestion to ...

The Food and Drug Administration has cleared the blood test to help diagnose Alzheimer's disease, potentially making it ...

A new Montana law looks to overhaul how pharmacy benefit managers operate, aiming to boost drug price transparency and ...

In a strange appeal to a right-wing conception of masculinity, Representative Tim Burchett proclaimed that he does not drink ...

If approved, mirdametinib is expected to be the first and only therapy in the European Union with marketing authorization for ...

Details aren't yet public but the plan is being overseen by the agency's new vaccine chief, Dr. Vinay Prasad, an outspoken critic of the FDA's handling of COVID-19 boosters. Makary and other Trump ...

India and the US are on the brink of a transformative bilateral trade agreement aimed at eliminating tariffs on a range of goods, potentially boosting trade from $200 billion to $500 billion by 2030.

- U.S. Food and Drug Administration (“FDA”) Commissioner identifies psychedelic drug development as a top agency priority in an effort to address unmet needs in mental health - - Calls for FDA ...